TLE2 antibody
Principal name
TLE2 antibody
Alternative names for TLE2 antibody
Transducin-like enhancer protein 2, TLE2, GRG2
Ncbi ID
NP_001138233.1, NP_001138233, NP_003251, 9606, NM_003260, NM_001144762, NP_062699.1, NM_019725
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Paraffin Sections (P), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of TLE2 antibody
The Notch signaling pathway controls cellular interactions important for the specification of a variety of fates in both invertebrates and vertebrates. Key players in the Notch pathway are the TLE genes (for transducin-like enhancer of split, also designated ESG for enhancer of split groucho), which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. TLEs associate with chromatin in live cells and specifically with Histone H3, but not with other core histones. Expression of the TLE genes, TLE1, TLE2, TLE3 and TLE4, correlate with immature epithelial cells that are progressing toward a terminally differentiated state, suggesting a role during epithelial differentiation. TLE1, TLE2 and TLE3 have elevated expression in cervial squamous metaplasias and carcinomas, while TLE4 is most highly expressed in the brain, particularly in the caudate nucleus. TLE1 and TLE4 contain SP and WD40 domains, through which TLE1 binds AML1 to inhibit AML1-induced transactivation of the CSF1 receptor.
General readings
Higa,L.A., (2006) Nat. Cell Biol. 8 (11), 1277-1283

















- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA504240 | TLE2 antibody |
||||||
| TLE2 mouse monoclonal antibody, clone OTI5A6 (formerly 5A6) | |||||||
![]() |
Mouse | IgG1 | OTI5A6 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
+11 additional images |
Highly validated antibody! |
||||||
| TA312089 | TLE2 antibody |
||||||
| Rabbit polyclonal anti-TLE2 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP06713PU-N | TLE2 antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu | E, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
| AP54267PU-N | TLE2 (C-term) antibody |
||||||
![]() |
Rabbit | Ig | Aff - Purified | Hu, Ms | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302474 | TLE2 (transcript variant 1) |
||||
| Recombinant protein of human transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) (TLE2), transcript variant 1 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY401124 | TLE2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY428507 | TLE2 overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR215597L2V | Lenti ORF particles, Tle2 (GFP-tagged) - Mouse transducin-like enhancer of split 2, homolog of Drosophila E(spl) (Tle2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,560.00
|
|
| OriGene Technologies, Inc. | ||
| MR215597L1V | Lenti ORF particles, Tle2 (Myc-DDK-tagged) - Mouse transducin-like enhancer of split 2, homolog of Drosophila E(spl) (Tle2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,400.00
|
|
| OriGene Technologies, Inc. | ||






+11 additional images




